Latest

Zantac
Pharmalot

Consumers sue Sanofi and other drug makers over Zantac link to a possible carcinogen

By Ed Silverman

Vertex Pharmaceuticals - sunset
Health

New Vertex cystic fibrosis drug approved, extending treatments to 90% of patients

By Andrew Joseph

Business

This is awkward: Genome editing startup Beam has competition — from one of its own cofounders

By Adam Feuerstein and Damian Garde

Backyard Chickens
Pharmalot

The use of antibiotics in food-producing livestock continues to drop in most of Europe

By Ed Silverman

Genome
In the Lab

New CRISPR tool has the potential to correct almost all disease-causing DNA glitches, scientists report

By Sharon Begley

Medicine world map
First Opinion

International pricing index ‘accomplishes nothing it sets out to do’

By Susan Peschin and Duane Schulthess

Business

Drug distributors and Teva reach tentative settlement of opioids lawsuit

By Associated Press

Pharmalot

Pharmalittle: Four drug companies settle Ohio opioid suit; J&J recalls baby powder due to asbestos

By Ed Silverman

heart-cholesterol
Health Tech

AI is used to mine health data to find undiagnosed patients, offering a model for other diseases

By Rebecca Robbins

Breast Cancer Cell - pink
Biotech

Seattle Genetics to seek approval for new breast cancer pill after positive clinical trial results

By Adam Feuerstein

The READOUT
The Readout

WeWork battles Alexandria & a threat to foreign biotech investment

By Meghana Keshavan

oxycodone opioid tablets
Morning Rounds

Bellwether opioid trial begins & Zantac pulled over contamination fears

By Shraddha Chakradhar

Mobile testing center in Los Angeles
First Opinion

Put communities at the center of universal health coverage

By Gunilla Carlsson, Katie Dain, and Rico Gustav

telehealth illo
First Opinion

Rapid expansion of telehealth comes with new challenges

By Linda A. Malek and Khaled Mowad

wework
Biotech

A biotech real estate firm wants a new slogan. WeWork says not so fast

By Kate Sheridan

Nigeria polio vaccine
Health

Two down, one to go: After decades-long campaign, type 3 polioviruses are set to be eradicated

By Helen Branswell

biotech invest
Biotech

Biotech worries new trade rules could sap foreign investment

By Damian Garde

Zantac
Pharmalot

Sanofi pulls Zantac from the U.S., joining a growing list of companies recalling heartburn meds

By Ed Silverman

STAT Plus: Our fourth quarter biotech scorecard

By Shraddha Chakradhar

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Bernie Sanders
Pharmalot

Sanders, other lawmakers say FDA is not being transparent about Takeda’s recall of lifesaving drug

By Ed Silverman

Pharmalot

Pharmalittle: Judge summons opioid CEOs before trial starts; Republicans fail to change Pelosi drug pricing bill

By Ed Silverman

European Medicines Agency
Health

With European backing, the world is on the brink of the first approved Ebola vaccine

By Helen Branswell

The READOUT
The Readout

Pharma’s future in China & Parker’s first biotech startup

By Damian Garde

Teen Juul
Morning Rounds

Juul quits selling some flavors & an exercise in pandemic preparedness

By Shraddha Chakradhar

GOP amendments to drug pricing bill
Politics

After 10 hours and a pile of rejected amendments, Democrats advance their drug pricing bill out of two key committees

By Nicholas Florko

Air pollution - industrial
First Opinion

New leaders needed to translate discoveries into patient care

By Robert Lechler

Qaali Hussein
First Opinion

Motherhood and medicine should mix. So why is it such a struggle?

By Qaali Hussein

Unnatural Selection Season 1 Episode 1 - Option 2
Biotech

The ‘unbelievable journey’ of CRISPR, now on Netflix

By Damian Garde and Adam Feuerstein

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy